Clinical and Translational Radiation Oncology

Papers
(The H4-Index of Clinical and Translational Radiation Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility31
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors29
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging26
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma23
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors16
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments16
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy16
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how16
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies14
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma13
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac12
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer12
Predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients using a deep learning model12
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial12
0.049345016479492